{"id":"W2835789356","doi":"10.1016/j.biopha.2018.06.157","title":"Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker","year":2018,"lang":"en","type":"article","venue":"Biomedicine & Pharmacotherapy","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Xenon Pharmaceuticals (Canada); University of British Columbia","funders":"National Institutes of Health; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Sodium channel; Pharmacology; Sodium channel blocker; Ventricular fibrillation; Chemistry; Sodium; Effective refractory period; Blockade; Potassium channel; Medicine; Anesthesia; Internal medicine; Refractory period; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001894755,0.0004291414,0.0004684401,0.0002584028,0.0001938674,0.0002618703,0.0004172354,0.0004882251,0.003537158],"category_scores_gemma":[0.0002578817,0.00015771,0.000374284,0.0001846456,0.0002941739,0.0003575385,0.0001837536,0.0009652426,0.0007165092],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000164126,"about_ca_system_score_gemma":0.0002932836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004562754,"about_ca_topic_score_gemma":0.0007470047,"domain_scores_codex":[0.9999012,0.00002520901,0.00001110758,0.0000173994,0.0000191147,0.0000260703],"domain_scores_gemma":[0.9999325,0.00001650837,0.00001271416,0.000009438892,0.000006683915,0.00002207151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005275146,0.0006697675,0.0004711924,0.000302488,0.0001102906,0.0003461439,0.00005361273,0.0003562698,0.9713014,0.0005261612,0.0009973223,0.01959006],"study_design_scores_gemma":[0.002300198,0.02420175,0.01152327,0.00006737496,0.0005057394,0.002761076,0.0001279535,0.002493295,0.9407479,0.000447795,0.01475691,0.00006670315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.97602,0.01269385,0.001922669,0.0005801191,0.0001575759,0.0001035196,0.0009102196,0.0002341433,0.007377938],"genre_scores_gemma":[0.9894413,0.005420437,0.001141351,0.0002008664,0.00006071599,0.00005448176,0.0008906006,0.00001648422,0.002773734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003537158,"threshold_uncertainty_score":0.01183295,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0278434512407923,"score_gpt":0.3214713316897302,"score_spread":0.293627880448938,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}